ImmunoGen’s Multi-Target License and Option Agreement with ImmunoBiochem

Pietro Martinoia
Tagged:

Ropes & Gray represented ImmunoGen in the deal.ImmunoGen, Inc. announced a multi-target license and option agreement to research novel, first-in-class ADCs with ImmunoBiochem Corporation on the discovery…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

…

This content is for Standard 1 Year members only.
Login Join Now